• Users Online: 39
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2016  |  Volume : 53  |  Issue : 2  |  Page : 96-101

Surgical strategy in the management of low-grade brain neoplasm with epilepsy: seizure outcome

Department of Neurosurgery, Ain Shams University, Cairo, Egypt

Correspondence Address:
Hatem A Sabry
MD, Department of Neurosurgery, Ain Shams University, 11361 Cairo
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/1110-1083.183435

Rights and Permissions

Background For 30-50% of patients with brain tumors, epileptic seizures are the presenting clinical sign of a tumor; 10-30% of patients develop seizures later during the disease course. Slow-growing tumors, (i.e. low-grade gliomata) are the most epileptogenic, although the high frequency of epilepsy in these patients might be related to longer survival from low-grade tumors. This study bears on this controversy through a prospective strategy in which patients were treated with excision of lesion together with epileptogenic area around, as defined using intraoperative electrocorticography. Patients and methods This is a prospective study designed to treat patients presenting between January 1997 and December 2011 with drug-resistant epilepsy (defined as failure to attain a seizure-free status utilizing adequate trials of two tolerated and appropriate antiepileptic drugs). Surgical procedure consisted of maximal resection of the tumor and any resectable surrounding associated with epileptogenic cortex, identified by means of intraoperative electrocorticography. Results Fifty-four patients were operated upon and followed up for a mean of 40 months (range = 6-72 months). Thirty-two tumors (59.2%) were located in the temporal lobe, 15 (27.8%) in the frontal lobe, and seven (13%) in the parietal lobe. The histopathology confirmed low-grade astrocytoma (WHO grade I or II) in 38.9% (n = 21) of patients, oligodendroglioma in 24% (n = 13), ganglioglioma in 20.4% (n = 11), and dysembryoplastic neuroepithelial tumor in 16.7% (n = 9) of patients. Gross total resection was achieved in 64.8% (n = 35) of patients and subtotal resection in 35.2% (n = 19) of patients. There was no death and five patients had permanent deficit. At follow-up, according to Engel's seizure outcome scale, 77.8% (n = 42) of the patients had good seizure control (classes I and II), and, collectively, 90.7% (n = 49) of patients had more than 75% reduction in seizures (class I-III). Conclusion In our series, we had a relatively high rate of gross total resection, which was associated with worthwhile seizure control, which compares favorably with a recent work that showed that the extent of resection significantly predicts seizure freedom following surgery. The favorable seizure outcome is tentatively attributed to the fact that all identified areas harboring epileptogenic activity around tumors were resected along with tumor resection.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded228    
    Comments [Add]    
    Cited by others 1    

Recommend this journal